Tian'an Pharmaceutical Co., Ltd.
TNPH
Rank in Stocks
#25687
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional... Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.
Share Price
$0.03
Last synced: 2026-11-10
Market Cap
$24.00M
Change (1 day)
0.00%
Change (1 year)
710.81%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tian'an Pharmaceutical Co., Ltd. (TNPH)
Category
Healthcare
EPS for Tian'an Pharmaceutical Co., Ltd. (TNPH)
EPS as of June 2026 TTM: 0.00
According to Tian'an Pharmaceutical Co., Ltd.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Tian'an Pharmaceutical Co., Ltd. from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | 0.00 | -50.00% |
| 2021 | 0.00 | -62.50% |
| 2020 | 0.00 | -30.43% |
| 2019 | 0.00 | 360.00% |
| 2018 | 0.00 | -100.51% |
| 2007 | $0.10 | -10.73% |
| 2006 | $0.11 | 37.50% |
| 2005 | $0.08 | 700.00% |
| 2004 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | - |
US
|
|
| $1.93 | - |
SE
|
|
| $6.91 | - |
FR
|
|
| $0.02 | - |
HK
|
|
| $2.71 | - |
IT
|
Questions about Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS)
What was Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Tian'an Pharmaceutical Co., Ltd.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.